Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.52 -0.09 (-3.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zentalis Pharmaceuticals (ZNTL) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Zentalis Pharmaceuticals (ZNTL) reported Depreciation & Amortization (CF) of $152,000 for Q2 2026, down 5.0% from $160,000 a year earlier but up 0.7% from the prior quarter.

Analysis

Zentalis Pharmaceuticals (ZNTL) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Zentalis Pharmaceuticals' Depreciation & Amortization (CF) came in at $620,000, down 42.1% year-over-year; for FY2025, it was $739,000, down 43.2% from FY2024.

  • Depreciation & Amortization (CF) has declined for three consecutive years, though with a five-year compound annual growth rate of 35.8% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $1.3 million in FY2024 (-7.1%), $1.4 million in FY2023 (-1.8%), $1.43 million in FY2022 (+162.1%) and $544,000 in FY2021 (+240.0%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $137,000 in Q3 2021 and a high of $375,000 in Q3 2022.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last six quarters, with an average decline of 27.3% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2021 (growth of 533.3%); the low point was Q4 2025 (a decline of 52.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $151,000 (Q1 2026), $157,000 (Q4 2025) and $160,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Zentalis Pharmaceuticals 187.05 Mn 187.05 Mn - 152,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 152,000.00
Mar 31, 2026 151,000.00
Dec 31, 2025 157,000.00
Sep 30, 2025 160,000.00
Jun 30, 2025 160,000.00
Mar 31, 2025 262,000.00
Dec 31, 2024 328,000.00
Sep 30, 2024 321,000.00
Jun 30, 2024 327,000.00
Mar 31, 2024 324,000.00
Dec 31, 2023 300,000.00
Sep 30, 2023 348,000.00
Jun 30, 2023 344,000.00
Mar 31, 2023 360,000.00
Dec 31, 2022 326,000.00
Sep 30, 2022 375,000.00
Jun 30, 2022 348,000.00
Mar 31, 2022 344,000.00
Dec 31, 2021 209,000.00
Sep 30, 2021 137,000.00
API Access

Zentalis Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ZNTL&period=max&api_key=YOUR_API_KEY